Pulse Biosciences (PLSE) Gross Profit (2021 - 2025)

Pulse Biosciences' Gross Profit history runs 3 years deep, the most recent figure standing at -$193000.0 for Q3 2025.

• On a quarterly basis, Gross Profit changed N/A year-over-year to -$193000.0 in Q3 2025; TTM through Sep 2025 was -$193000.0, a N/A change from a year earlier, with the FY2022 full-year figure at -$11.2 million, down 1879.58% from the prior year.
• Gross Profit grew to -$193000.0 in Q3 2025 per PLSE's latest filing, from -$1.3 million in the prior quarter.
• Across five years, Gross Profit topped out at -$153000.0 in Q3 2021 and bottomed at -$8.4 million in Q3 2022.
• The 3-year median for Gross Profit is -$465000.0 (2022), against an average of -$1.7 million.
• Biggest YoY gain for Gross Profit was 211.08% in 2022; the steepest drop was 5390.2% in 2022.
• Year by year, Gross Profit stood at -$415000.0 in 2021, then sank by 211.08% to -$1.3 million in 2022, then surged by 85.05% to -$193000.0 in 2025.
• Per Business Quant, the three latest PLSE Gross Profit figures stand at -$193000.0 (Q3 2025), -$1.3 million (Q4 2022), and -$8.4 million (Q3 2022).